tradingkey.logo

Inotiv Inc

NOTV
0.418USD
+0.028+7.26%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
14.37MMarktkapitalisierung
VerlustKGV TTM

Inotiv Inc

0.418
+0.028+7.26%

mehr Informationen über Inotiv Inc Unternehmen

Inotiv, Inc. is a contract research company engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Inotiv Inc Informationen

BörsenkürzelNOTV
Name des UnternehmensInotiv Inc
IPO-datumNov 25, 1997
CEOLeasure (Robert W)
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeNov 25
Addresse2701 Kent Ave
StadtWEST LAFAYETTE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl47906-1382
Telefon13174634527
Websitehttps://www.inotiv.com/
BörsenkürzelNOTV
IPO-datumNov 25, 1997
CEOLeasure (Robert W)

Führungskräfte von Inotiv Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
688.19K
-20125.00%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
378.73K
-22048.00%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
186.76K
+25000.00%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
65.54K
-11892.00%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
37.50K
-11892.00%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
19.00K
-36000.00%
Mr. R. Matthew Neff
Mr. R. Matthew Neff
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Robert W. Leasure, Jr.
Mr. Robert W. Leasure, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Beth A. Taylor
Ms. Beth A. Taylor
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Mr. David Landman
Mr. David Landman
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
688.19K
-20125.00%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
378.73K
-22048.00%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
186.76K
+25000.00%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
65.54K
-11892.00%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
37.50K
-11892.00%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
19.00K
-36000.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
447.98M
87.32%
Netherlands
35.48M
6.92%
Other
29.56M
5.76%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Wed, Feb 4
Aktualisiert: Wed, Feb 4
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
4.04%
Leasure (Robert Jr.)
3.55%
Balyasny Asset Management LP
2.87%
Sagartz (John E)
2.02%
GSA Capital Partners LLP
1.48%
Andere
86.05%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
4.04%
Leasure (Robert Jr.)
3.55%
Balyasny Asset Management LP
2.87%
Sagartz (John E)
2.02%
GSA Capital Partners LLP
1.48%
Andere
86.05%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
9.93%
Individual Investor
9.65%
Hedge Fund
6.87%
Investment Advisor/Hedge Fund
4.67%
Corporation
3.66%
Research Firm
2.33%
Venture Capital
0.33%
Bank and Trust
0.14%
Private Equity
0.06%
Andere
62.35%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
168
8.26M
24.01%
-3.92M
2025Q3
173
8.82M
25.69%
-3.41M
2025Q2
195
12.88M
37.49%
-4.07M
2025Q1
224
12.80M
37.26%
-4.48M
2024Q4
233
12.65M
38.89%
+1.31M
2024Q3
250
7.31M
26.57%
-8.16M
2024Q2
259
7.59M
28.13%
-9.62M
2024Q1
274
9.86M
38.07%
-7.14M
2023Q4
278
8.23M
31.98%
-10.32M
2023Q3
287
9.98M
38.79%
-9.73M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
1.40M
4.09%
+20.89K
+1.51%
Sep 30, 2025
Leasure (Robert Jr.)
1.24M
3.61%
+429.73K
+52.90%
Mar 14, 2025
Balyasny Asset Management LP
985.74K
2.87%
-668.91K
-40.43%
Sep 30, 2025
Sagartz (John E)
708.32K
2.06%
+30.00K
+4.42%
Mar 14, 2025
GSA Capital Partners LLP
234.52K
0.68%
+234.52K
--
Sep 30, 2025
UBS Financial Services, Inc.
314.55K
0.92%
+36.34K
+13.06%
Sep 30, 2025
Hardy (Adrian)
400.78K
1.17%
+25.00K
+6.65%
Mar 14, 2025
Renaissance Technologies LLC
359.76K
1.05%
-38.19K
-9.60%
Sep 30, 2025
Massar Capital Management, LP
350.00K
1.02%
--
--
Sep 30, 2025
Vantage Point Financial, LLC.
336.55K
0.98%
--
--
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Micro-Cap ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Core Equity Market ETF
0%
Avantis US Small Cap Value ETF
0%
Avantis US Equity ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
Anteil0.01%
Dimensional US Core Equity 1 ETF
Anteil0%
DFA Dimensional US Core Equity Market ETF
Anteil0%
Avantis US Small Cap Value ETF
Anteil0%
Avantis US Equity ETF
Anteil0%
Invesco RAFI US 1500 Small-Mid ETF
Anteil0%
Avantis US Small Cap Equity ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI